Trial · NCT03355209
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Part 1: Double-Blind Period | STARTED | Cohort A: Placebo | 87 | |
| Part 1: Double-Blind Period | STARTED | Cohort A: ZX008 0.2 mg/kg/Day | 89 | |
| Part 1: Double-Blind Period | STARTED | Cohort A: ZX008 0.8 mg/kg/Day | 87 | |
| Part 1: Double-Blind Period | STARTED | Cohort B: Placebo | 11 | |
| Part 1: Double-Blind Period | STARTED | Cohort B: ZX008 0.2 mg/kg/Day | 11 | |
| Part 1: Double-Blind Period | STARTED | Cohort B: ZX008 0.8 mg/kg/Day | 11 | |
| Part 1: Double-Blind Period | COMPLETED | Cohort A: Placebo | 86 | |
| Part 1: Double-Blind Period | COMPLETED | Cohort A: ZX008 0.2 mg/kg/Day | 83 | |
| Part 1: Double-Blind Period | COMPLETED | Cohort A: ZX008 0.8 mg/kg/Day | 81 | |
| Part 1: Double-Blind Period | COMPLETED | Cohort B: Placebo | 11 | |
| Part 1: Double-Blind Period | COMPLETED | Cohort B: ZX008 0.2 mg/kg/Day | 10 | |
| Part 1: Double-Blind Period | COMPLETED | Cohort B: ZX008 0.8 mg/kg/Day | 11 | |
| Part 1: Double-Blind Period | NOT COMPLETED | Cohort A: Placebo | 1 | |
| Part 1: Double-Blind Period | NOT COMPLETED | Cohort A: ZX008 0.2 mg/kg/Day | 6 | |
| Part 1: Double-Blind Period | NOT COMPLETED | Cohort A: ZX008 0.8 mg/kg/Day | 6 | |
| Part 1: Double-Blind Period | NOT COMPLETED | Cohort B: Placebo | 0 | |
| Part 1: Double-Blind Period | NOT COMPLETED | Cohort B: ZX008 0.2 mg/kg/Day | 1 | |
| Part 1: Double-Blind Period | NOT COMPLETED | Cohort B: ZX008 0.8 mg/kg/Day | 0 | |
| Part 2:Open-Label Extension (OLE) Period | STARTED | Cohort A: Placebo | 86 | |
| Part 2:Open-Label Extension (OLE) Period | STARTED | Cohort A: ZX008 0.2 mg/kg/Day | 83 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03355209/flow